| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Loans made | 0 | 0 |
| Net cash used in investing activities | 0 | 0 |
| Equity in loss of equity method investees | 0 | 0 |
| Gain on derivative instrument | 0 | 0 |
| Noncash disposal of equity method investment | 0 | - |
| Accrued expenses | 0 | 0 |
| Accretion of discount on note payable | 60,417 | 60,417 |
| Gain on disposal of equity method investment | 1,171,760 | 1,171,760 |
| Relief of indebtedness income | -1,697,024 | -1,697,024 |
| Accrued interest added to notes payable and convertible debt | 145,638 | 102,451 |
| Stock-based compensation | 8,838 | 8,838 |
| Accounts receivable, administrative fees | -10,500 | -10,500 |
| Prepaid expenses | -1,050 | -1,086 |
| Accounts payable | 31,712 | 28,374 |
| Net income (loss) | 2,469,177 | 2,546,625 |
| Net cash used in operating activities | -141,452 | -110,493 |
| Proceeds from convertible debt | 0 | - |
| Proceeds from issuance of long term notes payable | 0 | 0 |
| Proceeds from issuances of short term notes payable | 135,980 | 105,500 |
| Net cash provided by financing activities | 135,980 | 105,500 |
| Net change in cash | -5,472 | -4,993 |
| Cash and cash equivalents at beginning of period | 6,099 | - |
| Cash and cash equivalents at end of period | 627 | - |
NovelStem International Corp. (NSTM)
NovelStem International Corp. (NSTM)